# Open-Label Influenza Vaccine Evaluation

> **NCT02872311** · NA · COMPLETED · sponsor: **Marshfield Clinic Research Foundation** · enrollment: 179 (actual)

## Conditions studied

- Immune Response

## Interventions

- **BIOLOGICAL:** High Dose Influenza vaccine
- **BIOLOGICAL:** Adjuvanted Influenza vaccine
- **BIOLOGICAL:** Standard Dose Influenza vaccine
- **BIOLOGICAL:** Recombinant Influenza vaccine

## Key facts

- **NCT ID:** NCT02872311
- **Lead sponsor:** Marshfield Clinic Research Foundation
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2018-04
- **Final completion:** 2018-09
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2025-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02872311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02872311, "Open-Label Influenza Vaccine Evaluation". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT02872311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*